Decipher Labs — 360° view

Decipher Labs, a company in the Pharmaceuticals industry, reported revenue of ₹3.00 crore and a net loss of ₹14 crore for the September 2026 quarter.

Decipher Labs (BSE: DECIPHER) closed at ₹5.50 on 20 Nov 2026, down 46.8% over the past year. Its market capitalisation is ₹6 crore.

Share price
₹5.50 (20 Nov 2026)
Market cap
₹6 Cr (20 Nov 2026)
Revenue
₹3 Cr (September 2026 quarter)
Net profit
₹-14 Cr (September 2026 quarter)
ROCE
-16.7% (FY26)
ROE
-14.2% (FY26)
Book value
₹4.77 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹10.90 / ₹4.81 (20 Nov 2026)
1-year return
-46.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: DECIPHER

Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.